Fisher Paykel Healthcare Sees FY Revenue NZ$2.45B-NZ$2.57B
Fisher Paykel Healthcare Announces FY Revenue Guidance
Fisher & Paykel Healthcare Corporation Ltd expects its full-year operating revenue to be in the range of approximately NZ$2.45 billion to NZ$2.57 billion. The company also forecasts net profit after tax between NZ$500 million and NZ$550 million.
Improvement in Gross Margin Expected
Despite US tariffs and the Middle East conflict, the company anticipates an improvement in gross margin for the fiscal year. These developments provide key signals for investors.
Fisher Paykel Healthcare is a New Zealand-based medical device and respiratory products company. Its stock is listed on the NZX under the ticker FPH.
Impacted Symbols
Symbols affected by this headline and their sentiment signals
The news, analyses, and comments on this platform do not constitute investment advice. When making investment decisions, you should conduct your own research and consult with a qualified financial advisor if necessary. FiNews cannot be held responsible for any losses that may arise from the use of this information.